Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny L Pokorny

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Cell Science|June 28, 2024
Desmosomes at a glanceAbbey L Perl, Jenny L Pokorny, Kathleen J Green
Current Protocols in Pharmacology|July 12, 2011
Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discoveryBrett L Carlson, Jenny L Pokorny, Mark A Schroeder, et al.
Nature Cell Biology|May 3, 2011
WWP2 is an E3 ubiquitin ligase for PTENSubbareddy Maddika, Sridhar Kavela, Neelam Rani, et al.
Frontiers in Neuroscience|July 3, 2015
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiformeAmanda Tivnan, Zaitun Zakaria, Caitrín O'Leary, et al.
Scientific Reports|June 30, 2016
Network Modeling Identifies Patient-specific Pathways in GlioblastomaNurcan Tuncbag, Pamela Milani, Jenny L Pokorny, et al.
The Journal of Cell Biology|September 21, 2023
Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migrationHope E Burks, Jenny L Pokorny, Jennifer L Koetsier, et al.
Neuro-Oncology|May 15, 2015
Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastomaChani M Becker, Rajneet K Oberoi, Stephan J McFarren, et al.
Molecular Cancer Therapeutics|August 15, 2012
Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agentsSagar Agarwal, Rajendar K Mittapalli, David M Zellmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenograftsGaspar J Kitange, Ann C Mladek, Brett L Carlson, et al.
Journal of Neuro-Oncology|October 23, 2012
The role of LAT1 in (18)F-DOPA uptake in malignant gliomasRyan S Youland, Gaspar J Kitange, Timothy E Peterson, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Cell Science|June 28, 2024
Desmosomes at a glanceAbbey L Perl, Jenny L Pokorny, Kathleen J Green
Current Protocols in Pharmacology|July 12, 2011
Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discoveryBrett L Carlson, Jenny L Pokorny, Mark A Schroeder, et al.
Nature Cell Biology|May 3, 2011
WWP2 is an E3 ubiquitin ligase for PTENSubbareddy Maddika, Sridhar Kavela, Neelam Rani, et al.
Frontiers in Neuroscience|July 3, 2015
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiformeAmanda Tivnan, Zaitun Zakaria, Caitrín O'Leary, et al.
Scientific Reports|June 30, 2016
Network Modeling Identifies Patient-specific Pathways in GlioblastomaNurcan Tuncbag, Pamela Milani, Jenny L Pokorny, et al.
The Journal of Cell Biology|September 21, 2023
Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migrationHope E Burks, Jenny L Pokorny, Jennifer L Koetsier, et al.
Neuro-Oncology|May 15, 2015
Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastomaChani M Becker, Rajneet K Oberoi, Stephan J McFarren, et al.
Molecular Cancer Therapeutics|August 15, 2012
Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agentsSagar Agarwal, Rajendar K Mittapalli, David M Zellmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenograftsGaspar J Kitange, Ann C Mladek, Brett L Carlson, et al.
Journal of Neuro-Oncology|October 23, 2012
The role of LAT1 in (18)F-DOPA uptake in malignant gliomasRyan S Youland, Gaspar J Kitange, Timothy E Peterson, et al.
Pageof 2